Thymopoietin is a protein involved in the induction of CD90 in the thymus. The thymopoetin (TMPO) gene encodes three alternatively spliced mRNAs encoding proteins of 75 kDa (alpha), 51 kDa (beta) and 39 kDa (gamma) which are ubiquitously expressed in all cells. The human TMPO gene maps to chromosome band 12q22 and consists of eight exons. TMPO alpha is present diffusely expressed with the cell nucleus while TMPO beta and gamma are localized to the nuclear membrane. TMPO beta is a human homolog of the murine protein LAP2. LAP2 plays a role in the regulation of nuclear architecture by binding lamin B1 and chromosomes. This interaction is regulated by phosphorylation during mitosis. Given the nuclear localization of the three TMPO isoforms, it is unlikely that these proteins play any role in CD90 induction.
^Furukawa K (Aug 1999). "LAP2 binding protein 1 (L2BP1/BAF) is a candidate mediator of LAP2-chromatin interaction". Journal of Cell Science. 112 ( Pt 15) (15): 2485–92. doi:10.1242/jcs.112.15.2485. PMID10393804.
^Foisner R, Gerace L (Jul 1993). "Integral membrane proteins of the nuclear envelope interact with lamins and chromosomes, and binding is modulated by mitotic phosphorylation". Cell. 73 (7): 1267–79. doi:10.1016/0092-8674(93)90355-T. PMID8324822. S2CID10641633.
Harris CA, Andryuk PJ, Cline SW, Mathew S, Siekierka JJ, Goldstein G (Jul 1995). "Structure and mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO beta to rat lamin-associated polypeptide 2". Genomics. 28 (2): 198–205. doi:10.1006/geno.1995.1131. PMID8530026.
Dechat T, Vlcek S, Foisner R (Apr 2000). "Review: lamina-associated polypeptide 2 isoforms and related proteins in cell cycle-dependent nuclear structure dynamics". Journal of Structural Biology. 129 (2–3): 335–45. doi:10.1006/jsbi.2000.4212. PMID10806084.
Heavner GA, Audhya T, Goldstein G (Feb 1990). "Peptide analogs of thymopentin distinguish distinct thymopoietin receptor specificities on two human T cell lines". Regulatory Peptides. 27 (2): 257–62. doi:10.1016/0167-0115(90)90044-W. PMID2158125. S2CID12562672.
Fuccello A, Audhya T, Talle MA, Goldstein G (Jan 1984). "Immunoassay for bovine serum thymopoietin: discrimination from splenin by monoclonal antibodies". Archives of Biochemistry and Biophysics. 228 (1): 292–8. doi:10.1016/0003-9861(84)90070-5. PMID6364989.
Hara H, Hayashi K, Ohta K, Itoh N, Ohta M (Nov 1994). "A new thymopoietin precursor gene from human thymus". Biochemistry and Molecular Biology International. 34 (5): 927–33. PMID7703909.
Harris CA, Andryuk PJ, Cline SW, Mathew S, Siekierka JJ, Goldstein G (Jul 1995). "Structure and mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO beta to rat lamin-associated polypeptide 2". Genomics. 28 (2): 198–205. doi:10.1006/geno.1995.1131. PMID8530026.
Andersson B, Wentland MA, Ricafrente JY, Liu W, Gibbs RA (Apr 1996). "A "double adaptor" method for improved shotgun library construction". Analytical Biochemistry. 236 (1): 107–13. doi:10.1006/abio.1996.0138. PMID8619474.
Furukawa K (Aug 1999). "LAP2 binding protein 1 (L2BP1/BAF) is a candidate mediator of LAP2-chromatin interaction". Journal of Cell Science. 112 ( Pt 15) (15): 2485–92. doi:10.1242/jcs.112.15.2485. PMID10393804.
Weber PJ, Eckhard CP, Gonser S, Otto H, Folkers G, Beck-Sickinger AG (Jun 1999). "On the role of thymopoietins in cell proliferation. Immunochemical evidence for new members of the human thymopoietin family". Biological Chemistry. 380 (6): 653–60. doi:10.1515/BC.1999.081. PMID10430029. S2CID12957414.